Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Nuclear Medicine Communications
|
November 14, 1997
Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients
S A McQuarrie, R P Baum, A Niesen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2015
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status
L Bodei, M Kidd, I M Modlin, et al.
European Journal of Nuclear Medicine
|
January 1, 1990
Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments
A Chetanneau, R P Baum, P A Lehur, et al.
Clinical & Experimental Metastasis
|
August 8, 2014
The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm
D Kaemmerer, N Posorski, F von Eggeling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 5, 2016
Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up
Dieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 8, 2013
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
L Bodei, J Mueller-Brand, R P Baum, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 25, 2012
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry
Dieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Nuklearmedizin. Nuclear Medicine
|
February 17, 2015
[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)]
T D Poeppel, C Boy, A Bockisch, et al.
Nuklearmedizin. Nuclear Medicine
|
March 15, 2018
[Somatostatin receptor PET/CT (SSTR-PET/CT)]
C Boy, T Poeppel, J Kotzerke, et al.
Der Pathologe
|
May 20, 2015
[Neuroendocrine neoplasms of the breast]
M Anlauf, M Neumann, S Bomberg, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Nuclear Medicine Communications
|
November 14, 1997
Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients
S A McQuarrie, R P Baum, A Niesen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2015
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status
L Bodei, M Kidd, I M Modlin, et al.
European Journal of Nuclear Medicine
|
January 1, 1990
Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments
A Chetanneau, R P Baum, P A Lehur, et al.
Clinical & Experimental Metastasis
|
August 8, 2014
The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm
D Kaemmerer, N Posorski, F von Eggeling, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 5, 2016
Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up
Dieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 8, 2013
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
L Bodei, J Mueller-Brand, R P Baum, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 25, 2012
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry
Dieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Nuklearmedizin. Nuclear Medicine
|
February 17, 2015
[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)]
T D Poeppel, C Boy, A Bockisch, et al.
Nuklearmedizin. Nuclear Medicine
|
March 15, 2018
[Somatostatin receptor PET/CT (SSTR-PET/CT)]
C Boy, T Poeppel, J Kotzerke, et al.
Der Pathologe
|
May 20, 2015
[Neuroendocrine neoplasms of the breast]
M Anlauf, M Neumann, S Bomberg, et al.
Page
of 14